Yogesh Subramanian | Health Professions | Academic Excellence Award

Assist. Prof. Dr. Yogesh Subramanian | Health Professions | Academic Excellence Award

Madras Medical college | India

Dr. Yogesh S., M.D., is a dedicated and accomplished medical educator and clinician based in Chennai, India, with a strong commitment to advancing medical education and clinical excellence. He earned his Doctorate in Medicine (M.D.) from Government Stanley Medical College, Chennai, under The Tamil Nadu Dr. M.G.R. Medical University, following his M.B.B.S. from PSG Institute of Medical Sciences, Coimbatore. His professional journey began as an Assistant Surgeon at the Government Upgraded PHC, Nambiyur, Erode HUD (2015–2017), followed by serving as a Junior Resident in General Medicine at Government Stanley Medical College (2017–2020). Currently, he holds the position of Senior Assistant Professor at the Institute of Internal Medicine, Madras Medical College and Rajiv Gandhi Government General Hospital, where he continues to contribute to clinical education and patient care. Dr. Yogesh is an expert in clinical procedures such as intubation and central line placement and is recognized for his effective teaching, leadership, and communication skills. He has actively engaged in Faculty Development Programs, Curriculum Implementation Courses, and Critical Care training to enhance his pedagogical and clinical expertise. His research and innovation in medical teaching have earned him opportunities to present at national and international conferences, including OTTAWA 2024 in Melbourne and APICON 2024 in Delhi. A lifetime member of AHPE, IMA, API, and NFED, Dr. Yogesh also serves as a jury and judge at academic events, reflecting his passion for nurturing the next generation of medical professionals and strengthening the standards of medical education in India.

Profiles: Orcid | Google Scholar

Featured Publications 

Sud, R., Agarwal, N., Aishwarya, V., Aggarwal, A., Kalawatia, M., Sangoi, R., et al. (2023). A case series of dengue myocarditis: A complication observed in dengue patients. Cureus, 15(11).

Nallathambi, N., & Chinnadurai, A. (2024). Carboplatin-induced hematuria with obstructive acute kidney injury. Cureus, 16(4).

Kothari, R., Johny, M. P., Mistry, D., Irfana, M., Yogesh, S., & Vemparala, S. S. (2024). Grip to health: Unlocking the clinical potential of isometric hand grip strength – A narrative review. Journal of Pharmacy and Bioallied Sciences, 16(Suppl 4), S3102–S3104.

Prashanth, A., Kothari, R., Yogesh, S., Mittal, G., Gheewala, S., Bokariya, P., et al. (2023). Examining body fat percentage, galvanic skin response, and muscle grip strength in female hypothyroid patients. Cureus, 15(7).

Mittal, G., Prashanth, A., Dhali, A., Prasad, R., Yogesh, S., Nurani, K. M., et al. (2025). Plant extracts with antioxidant and hepatoprotective benefits for liver health: A bibliometric analysis of drug delivery systems. World Journal of Gastroenterology, 31(18), 105836.

PRAJAKTA MASURKAR | Health Professions | Best Researcher Award

Dr. PRAJAKTA MASURKAR | Health Professions | Best Researcher Award

👤 Dr. PRAJAKTA MASURKAR, UCB, United States

Prajakta P. Masurkar, Ph.D., MPharm, is a dynamic HEOR (Health Economics and Outcomes Research) professional specializing in evidence generation for payer-focused strategies in inflammatory and rare diseases. With over 7 years of experience in HEOR research and an additional 3 years in the pharmaceutical industry, Dr. Masurkar excels in retrospective data analysis, economic modeling, patient-reported outcomes strategies, and advanced research designs. Her expertise extends to clinical development, market access, and health technology assessments (HTAs). Currently serving as HEOR Associate Director at UCB, Atlanta, she leads impactful research initiatives, integrating US payer evidence with global strategies. A skilled communicator and strategic thinker, she has a proven ability to deliver research outcomes aligning with business development and policy objectives. Dr. Masurkar’s academic journey includes a Ph.D. in Pharmaceutical Health Outcomes and Policy, reflecting her dedication to advancing healthcare innovation and enhancing the patient experience through data-driven insights.

Professional Profile

Scopus 

Orcid

🌟  Summary of Suitability for the Award

Dr. Prajakta P. Masurkar is an exemplary candidate for the “Research for Best Researcher Award.” With a profound blend of academic accomplishments, industry experience, and research expertise, Dr. Masurkar has significantly contributed to the fields of Health Economics and Outcomes Research (HEOR), pharmacoepidemiology, and pharmacoeconomics. Her seven years of HEOR research experience and additional three years in the pharmaceutical industry showcase her depth of knowledge and versatility in tackling complex challenges related to health economics, payer strategies, and clinical evidence generation.

Dr. Masurkar’s impactful work is evident in her leadership roles, including her current position as Associate Director at UCB and her tenure at Amgen, where she spearheaded numerous research initiatives. Her contributions span diverse therapeutic areas, including dermatology, inflammation, lupus, and rare diseases.

🎓 Education

Dr. Prajakta P. Masurkar holds a Ph.D. in Pharmaceutical Health Outcomes and Policy from the University of Houston, Texas, USA (2017–2021). Her doctoral research emphasized pharmacoepidemiology and pharmacoeconomics, honing her expertise in health outcomes research. She earned her Master of Pharmacy (MPharm) in Drug Development and Regulatory Affairs from Narsee Monjee Institute of Management Studies (NMIMS), Mumbai, India, with a focus on innovative analytical methods and regulatory frameworks. Dr. Masurkar’s academic journey began with a Bachelor of Pharmacy (BPharm) from the University of Mumbai, India, where she developed foundational knowledge in pharmaceutical sciences. Throughout her education, she maintained impressive GPAs, showcasing her academic rigor and commitment to excellence. Her multidisciplinary training equips her with the skills to navigate complex health economic evaluations, evidence generation, and global regulatory landscapes, enabling her to make meaningful contributions to the field of healthcare research and policy development.

💼  Professional Experience

Dr. Prajakta P. Masurkar’s professional journey spans over a decade of impactful roles in Health Economics and Outcomes Research (HEOR) and the pharmaceutical industry. As HEOR Associate Director at UCB, Atlanta, she leads evidence generation initiatives for dermatology, integrating global strategies with US payer requirements. At Amgen, she held senior and managerial positions, driving HEOR strategies for inflammation-related conditions, including lupus and atopic dermatitis. Her responsibilities encompassed economic modeling, real-world evidence studies, and HTA submissions. Earlier roles included a Global HEOR internship at Intuitive Surgical, where she developed cost-effectiveness analyses for robotic-assisted surgeries, and a Teaching Assistantship at the University of Houston. In India, she contributed to pharmacovigilance and regulatory affairs with leading pharmaceutical firms. Dr. Masurkar’s cross-functional collaborations, strategic leadership, and technical expertise underscore her commitment to advancing patient care and optimizing healthcare value propositions through evidence-based solutions.

🏅 Awards and Recognition

Dr. Prajakta P. Masurkar has earned recognition for her exceptional contributions to health economics and outcomes research. Her achievements include impactful presentations at esteemed conferences such as the American College of Rheumatology (ACR) Annual International Meeting, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and the Academy of Managed Care Pharmacy (AMCP). Notable podium and poster presentations highlight her groundbreaking work on treatment patterns, healthcare resource utilization, and cost analyses in systemic lupus erythematosus. Her expertise in economic modeling and patient-reported outcomes strategies has been acknowledged with invitations to present globally. Additionally, her dedication to advancing health outcomes research has been celebrated with opportunities to mentor and collaborate with global experts. These recognitions reflect Dr. Masurkar’s unwavering commitment to excellence and her influential role in shaping innovative solutions for complex healthcare challenges.

🌍 Research Skills On Health Professions

Dr. Prajakta P. Masurkar possesses a diverse and advanced skill set in health economics and outcomes research. Her expertise includes economic modeling, health technology assessments (HTA), and patient-reported outcomes (PRO) strategies, tailored to improve healthcare access and optimize payer value propositions. She is adept in retrospective claims analysis, real-world evidence (RWE) studies, and systematic reviews, leveraging extensive experience with databases like MarketScan, Medicare, and EMR systems. Proficient in programming tools like R, Python, and SAS, Dr. Masurkar applies quantitative and qualitative methods to generate impactful evidence. She excels in decision-analytic modeling and cost-effectiveness analyses, enhancing decision-making for stakeholders. Her technical acumen extends to scientific writing, including Global Value Dossiers (GVD) and HTA submissions, ensuring compliance and effectiveness. With an innovative approach and a commitment to precision, Dr. Masurkar’s research skills empower her to deliver solutions addressing critical gaps in healthcare.

📖 Publication Top Notes

1. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
  • Citation: Drugs & Aging, DOI: 10.1007/s40266-022-00944-z
  • Year: 2022
2. Risk of Overactive Bladder Associated With Cholinesterase Inhibitors in Dementia
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
  • Citation: Journal of the American Geriatrics Society, DOI: 10.1111/jgs.17579
  • Year: 2022
3. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Rajender R. Aparasu
  • Citation: Drugs & Aging, DOI: 10.1007/s40266-021-00863-5
  • Year: 2021
4. A Naturalistic Observation Study of Medication Counseling Practices at Retail Chain Pharmacies
  • Authors: Soham D. Yande, Prajakta P. Masurkar, Suma Gopinathan, Sujit Sansgiry
  • Citation: Pharmacy Practice, DOI: 10.18549/PharmPract.2020.1.1696
  • Year: 2020
5. A Need of Better Pharmacovigilance System in India
  • Authors: Prajakta P. Masurkar
  • Citation: Asian Journal of Pharmaceutical and Clinical Research, DOI: 10.22159/ajpcr.2017.v10i1.14797
  • Year: 2017